RE:RE:RE:But... They have to do a monthly report
here is the full report for April 3 2024
MONTHLY PROGRESS REPORT
Name of Listed Issuer: Justera Health Ltd.
(the “Issuer”).
Trading Symbol: VTAL
Number of Outstanding Listed Securities: 160,805,583
Date: April 3, 2024
This Monthly Progress Report must be posted before the opening of trading on the fifth
trading day of each month. This report is not intended to replace the Issuer’s obligation
to separately report material information forthwith upon the information becoming known
to management or to post the forms required by Exchange Policies. If material
information became known and was reported during the preceding month to which this
`report relates, this report should refer to the material information, the news release date
and the posting date on the Exchange website.
This report is intended to keep investors and the market informed of the Issuer’s ongoing
business and management activities that occurred during the preceding month. Do not
discuss goals or future plans unless they have crystallized to the point that they are
"material information" as defined in the Policies. The discussion in this report must be
factual, balanced and non-promotional.
The Company continues to undertake various initiatives to strategically restructure the business and enhance operational efficiency in alignment
with the established direction.
Management focuses its business on the health and wellness industry and
is making efforts to strengthen its capabilities. Certificate Of Compliance
The undersigned hereby certifies that:
1. The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution of the board of directors of the Issuer to sign this Certificate of Compliance.
2. As of the date hereof there were is no material information concerning the Issuer which has not been publicly disclosed.
3. The undersigned hereby certifies to the Exchange that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as defined in CNSX Policy 1).
4. All of the information in this Form 7 Monthly Progress Report is true.
Dated April 3, 2024 .
Young Cho Lee Name of Director or Senior Officer
/s/ “Young Cho Lee”
Signature
CEO Official Capacity
Issuer Details
Name of Issuer
Justera Health Ltd. Issuer Address
2300 Yonge Street, Suite 2802
City/Province/Postal Code
Toronto, ON M4P 1E4
Contact Name
Young Cho Lee
For Month
End
March
2024
Issuer Fax No. N/A
Contact Position CEO
Date of Report
YY/MM/DD
24/04/03
Issuer Telephone No. (416) 901 5611
Contact Telephone No. (416) 901 5611
Contact Email Address info@justerahealth.com
Web Site Address www.justerahealth.com